All news

Director Howard Welgus proposes selling 4,728 Arcutis (ARQT) shares around November 16.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Arcutis Biotherapeutics, Inc. director Howard Welgus has proposed selling 4,728 common shares of the company, with an approximate sale date of November 16, 2026, and an aggregate market value of

Read original source

ARQT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.